Evaluation of the pharmacological potential of N-((5-phenyl-6,11-dihydro-[1,2,4]triazolo[1’,5’:1,6]pyrido[3,4-b]indol-2-yl)methyl)benzamides

Authors

DOI:

https://doi.org/10.14739/2409-2932.2025.2.328643

Keywords:

1,2,4-triazole, indole core, in silico evaluation, safety

Abstract

The rational design of new biologically active compounds is based on the use of effective structural fragments, capable of ensuring high biosimilarity, favorable pharmacokinetic properties and an appropriate safety profile. Among them, 1,2,4-triazole and indole cores occupy a special place, being widely represented in pharmacologically active molecules due to their ability to participate in various types of molecular interactions. The combination of 1,2,4-triazole and indole fragments within a single molecule promotes the creation of conjugated systems with potentially multifunctional activity, thereby expanding the opportunities for the discovery of new therapeutic agents. Early-stage computer-based prediction of toxicological and pharmacokinetic properties remains a key strategy for optimizing the screening process. The application of in silico methods allows timely assessment of the safety, ADME profile and biological potential of compounds prior to experimental investigations.

Aim. This study aimed to perform an in silico assessment of the toxicological properties, ADME parameters, and molecular docking profiles of newly designed compounds belonging to the N-((5-phenyl-6,11-dihydro-[1,2,4]triazolo-[1’,5’:1,6]pyrido[3,4-b]indol-2-yl)methyl)benzamide series, in order to substantiate their synthesis and guide further experimental validation.

Materials and methods. Molecular structure design for in silico studies was guided by a critical analysis of the scientific literature and fundamental principles of organic chemistry, allowing the rational incorporation of established pharmacophoric elements into compact molecular frameworks. Safety profiles and potential toxicological risks were predicted using the TEST (Toxicity Estimation Software Tool) platform. Physicochemical properties and pharmacokinetic behaviors were evaluated through the SwissADME online resource. Advanced molecular docking techniques were employed to identify potential binding sites with model enzymes and to characterize the energetic and spatial features of ligand-target interactions. Ligand structures were generated using MarvinSketch 6.3.0, HyperChem 8, and AutoDock Tools 1.5.6, while protein targets were prepared with Discovery Studio 4.0 and AutoDock Tools 1.5.6. Docking simulations were conducted with AutoDock Vina, enabling accurate modeling of ligand-protein binding based on energetic and steric complementarity. This integrative in silico approach facilitated the early-stage evaluation of biological potential and safety profiles prior to experimental validation.

Results. The investigated N-((5-phenyl-6,11-dihydro-[1,2,4]triazolo-[1’,5’:1,6]pyrido[3,4-b]indol-2-yl)methyl)benzamide derivatives exhibited statistically significant moderate to low toxicity towards aquatic organisms (Daphnia magna, Pimephales promelas) and lacked mutagenic potential. The predicted oral toxicity values (LD50) in rats ranged from 470 mg/kg to 990 mg/kg, indicating a relatively safe profile for the compounds. Pharmacokinetic analysis revealed high aromaticity, a low degree of carbon bond saturation, and variable water solubility among the studied compounds. The most favorable properties were observed for 2-bromo-4-fluoro-N-((5-phenyl-6,11-dihydro-[1,2,4]triazolo[1’,5’:1,6]pyrido[3,4-b]-indol-2-yl)methyl)benzamide, 2-bromo-N-((5-phenyl-6,11-dihydro-[1,2,4]triazolo-[1’,5’:1,6]pyrido[3,4-b]indol-2-yl)methyl)benzamide, 4-fluoro-N-((5-phenyl-6,11-dihydro-[1,2,4]triazolo[1’,5’:1,6]pyrido[3,4-b]indol-2-yl)methyl)benzamide and N-((5-phenyl-6,11-dihydro-[1,2,4]triazolo[1’,5’:1,6]pyrido[3,4-b]indol-2-yl)methyl)-thiophene-2-carboxamide. These compounds were identified as the most promising candidates for further synthesis and biological evaluation.

Conclusions. Computer modeling demonstrated that a series of designed N-((5-phenyl-6,11-dihydro-[1,2,4]triazolo[1’,5’:1,6]pyrido[3,4-b]indol-2-yl)methyl)-benzamide derivatives is characterized by a relatively safe toxicological profile, absence of mutagenic potential and favorable pharmacokinetic properties. Based on comprehensive in silico evaluation, four compounds exhibiting the most promising characteristics in terms of safety and potential bioactivity are recommended for further experimental studies.

Author Biographies

S. O. Fedotov, Zaporizhzhia State Medical and Pharmaceutical University

Senior Lecturer of the Department of Toxicological and Inorganic Chemistry

A. S. Hotsulia, Zaporizhzhia State Medical and Pharmaceutical University

Phd, DSc, Associate Professor, Professor of the Department of Toxicological and Inorganic Chemistry

References

Yele V, Pindiprolu SK, Sana S, Ramamurty DS, Madasi JR, Vadlamani S. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines. Anticancer Agents Med Chem. 2021;21(8):1047-55. doi: https://doi.org/10.2174/1871520620666200925102940

Mahmoud E, Abdelhamid D, Mohammed AF, Almarhoon ZM, Bräse S, Youssif BG, et al. Design, synthesis, and antiproliferative activity of novel indole/1,2,4-triazole hybrids as tubulin polymerization inhibitors. Pharmaceuticals. 2025;18(2):275. doi: https://doi.org/10.3390/ph18020275

Berwal P, Rohilla S, Mathur N, Rani K. Synthesis, molecular docking, and biological evaluation of novel indole-triazole conjugates. Curr Drug Discov Technol. 2024;21(6):e120324227917. doi: https://doi.org/10.2174/0115701638295739240222074426

Pravin NJ, Kavalapure RS, Alegaon SG, Gharge S, Ranade SD. Indoles as promising Therapeutics: A review of recent drug discovery efforts. Bioorg Chem. 2025;154:108092. doi: https://doi.org/10.1016/j.bioorg.2024.108092

Shcherbyna R, Panasenko O, Polonets O, Nedorezanıuk N, Duchenko M. Synthesis, antimicrobial and antifungal activity of ylidenhydrazides of 2-((4-R-5-R1-4Н-1,2,4-triazol-3-yl)thio)acetaldehydes. Journal of Faculty of Pharmacy of Ankara University. 2021;45(3):504-14. doi: https://doi.org/10.33483/jfpau.939418

Samelyuk Y, Kaplaushenko A. Synthesis of 3-alkylthio(sulfo)-1,2,4-triazoles, containing methoxyphenyl substituents at C5atoms, their antipyretic activity, propensity to adsorption and acute toxicity. J Chem Pharm Res. 2014:6(5):1117-21.

Safonov A. Method of synthesis novel N'-substituted 2-((5-(thiophen-2-ylmethyl)-4H-1,2,4-triazol-3-yl)thio)acetohydrazides. Journal of Faculty of Pharmacy of Ankara University. 2020;44(2):242-52. doi: https://doi.org/10.33483/jfpau.580011

Gotsulya A, Fedotov S, Zinych O, Trofimova T, Brytanova T. Synthesis and properties of S-alkyl 4-(4-chlorophenyl)-5-(pyrrole-2-yl)-1,2,4-triazole-3-thiol derivatives. Journal of Faculty of Pharmacy of Ankara University. 2023;47(3):1020-32. doi: https://doi.org/10.33483/jfpau.1280492

Karpenko Y, Hunchak Y, Gutyj B, Hunchak A, Parchenko M, Parchenko V. Advanced research for physico-chemical properties and parameters of toxicity piperazinium 2-((5-(furan-2-yl)-4-phenyl-4H-1,2,4-triazol-3-yl)thio)acetate. ScienceRise: Pharmaceutical Science. 2022;(2):18-25. doi: https://doi.org/10.15587/2519-4852.2022.255848

Demchenko S, Lesyk R, Yadlovskyi O, Holota S, Yarmoluk S, Tsyhankov S, et al. Fused triazole-azepine hybrids as potential non-steroidal antiinflammatory agents. Scientia pharmaceutica. 2023;91(2):26-6. doi: https://doi.org/10.3390/scipharm91020026

US EPA O. Toxicity Estimation Software Tool (TEST) [Internet]. www.epa.gov. 2020. Available from: https://www.epa.gov/comptox-tools/toxicity-estimation-software-tool-test

Biovia [Internet]. Dassault Systèmes. 2023 [cited 2025 Apr 11]. Available from: http://www.3dsbiovia.com

Chemaxon [Internet]. MarvinSketch, Version 6.3.0. [Software] [cited 2025 Apr 11]. Available from: http://www.chemaxon.com

Protein Data Bank [Internet]; [сited 2025 Apr 11]. Available from: https://www.wwpdb.org/

Additional Files

Published

2025-07-04

How to Cite

1.
Fedotov SO, Hotsulia AS. Evaluation of the pharmacological potential of N-((5-phenyl-6,11-dihydro-[1,2,4]triazolo[1’,5’:1,6]pyrido[3,4-b]indol-2-yl)methyl)benzamides. Current issues in pharmacy and medicine: science and practice [Internet]. 2025Jul.4 [cited 2025Jul.6];18(2):148-59. Available from: https://pharmed.zsmu.edu.ua/article/view/328643